Unknown PHASE1 INTERVENTIONAL NCT00033046

Evaluation of Modafinil as a Cocaine Treatment Medication and Interactions With Cocaine - 1

Safety Evaluation of Cocaine Treatment Medication Modafinil: Interactions With Intravenous Cocaine

Sponsor: National Institute on Drug Abuse (NIDA)

Conditions Cocaine-Related Disorders Drug Administration Schedule Infusions, Intravenous

Interventions Modafinil

Updated 5 times since 2017 Last updated: Jan 10, 2017 Started: Jun 30, 2001 Completion: Apr 30, 2002

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Cocaine-Related Disorders and Drug Administration Schedule, this trial is ongoing. The trial is conducted by National Institute on Drug Abuse (NIDA) and has accumulated 5 data snapshots since 2001. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE1
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE1
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE1
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE1

First recorded

Jun 2001

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute on Drug Abuse (NIDA)

Data source: National Institute on Drug Abuse (NIDA)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Charleston, United States